Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents

American Journal of Pathology

Volumn 168, Issue 4, 2006, Pages 1148-1154

  Ferrier, Laurent ^a,b   Bérard, Florian ^a   Debrauwer, Laurent ^a   Chabo, Chantal ^a   Langella, Philippe ^b   Buéno, Lionel ^a   Fioramonti, Jean ^a  

^a CNRS   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; AMPICILLIN; ANTIBIOTIC AGENT; DOXANTRAZOLE; EDETATE CHROMIUM CR 51; ENDOTOXIN; NEOMYCIN;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; COLON MUCOSA; CONTROLLED STUDY; ENDOTOXEMIA; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIVER TOXICITY; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 33645449666     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050617     Document Type: Article

References (25)

1. Willis MS, Klassen LW, Tuma DJ, Sorrell MF, Thiele GM: Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res 2002, 26:94-106
2. Arteel G, Marsano L, Mendez C, Bentley F, McClain CJ: Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol 2003, 17:625-647
3. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, Girona E, Gutierrez A, Carnices F, Palazon JM, Sola-Vera J, Perez-Mateo M: Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003, 50:1482-1486
4. Rao RK, Seth A, Sheth P: Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol 2004, 286:G881-G884
5. Wheeler MD: Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 2003, 27:300-306
6. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C: Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000, 32:742-747
7. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ: Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 2001, 299:442-448
8. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N: Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol 1999, 276:G965-G974
9. Levitt MD, Doizaki W, Levine AS: Hypothesis: metabolic activity of the colonie bacteria influences organ injury from ethanol. Hepatology 1982, 2:598-600
10. Baraona E, Julkunen R, Tannenbaum L, Lieber CS: Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 1986, 90:103-110
11. Atkinson KJ, Rao RK: Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. Am J Physiol 2001, 280:G1280-G1288
12. Santos J, Yang PC, Soderholm JD, Benjamin M, Perdue MH: Role of mast cells in chronic stress induced colonie epithelial barrier dysfunction in the rat. Gut 2001, 48:630-636
13. McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK: Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 2003, 100:7761-7766
14. Koivisto T, Kaihovaara P, Salaspuro M: Acetaldehyde induces histamine release from purified rat peritoneal mast cells. Life Sci 1999, 64:183-190
15. Gukovskaya AS, Mouria M, Gukovsky I, Reyes CN, Kasho VN, Faller LD, Pandol SJ: Ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats. Gastroenterology 2002, 122:106-118
16. Hashimoto N, Ohyanagi H: Effect of acute portal hypertension on gut mucosa. Hepatogastroenterology 2002, 49:1567-1570
17. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A: Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther 1999, 291:1075-1085
18. Rosenberg DW, Mankowski DC: Induction of cyp2e-1 protein in mouse colon. Carcinogenesis 1994, 15:73-78
19. Jokelainen K, Siitonen A, Jousimies-Somer H, Nosova T, Heine R, Salaspuro M: In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in man. Alcohol Clin Exp Res 1996, 20:967-972
20. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M: Ciprofloxacin decreases the rate of ethanol elimination in humans. Gut 1999, 44:347-352
21. Visapaa JP, Jokelainen K, Nosova T, Salaspuro M: Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin. Alcohol Clin Exp Res 1998, 22:1161-1164
22. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997, 77:1033-1079
23. Barreau F, Ferrier L, Fioramonti J, Bueno L: Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut 2004, 53:501-506
24. Batchelor JF, Follenfant MJ, Garland LG, Gorvin JH, Green AF, Hodson HF, Hughes DT, Tateson JE: Doxantrazole, an antiallergic agent orally effective in man. Lancet 1975, 1:1169-1170
25. Sadeghi-Hashjin G, Nijkamp FP, Henricks PA, Folkerts G: Sodium cromoglycate and doxantrazole are oxygen radical scavengers. Eur Respir J 2002, 20:867-872